(-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009043:Motor Activity / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug; D012559:Schizophrenia / Q000503:physiopathology; D012701:Serotonin / Q000378:metabolism / Q000502:physiology; D012702:Serotonin Antagonists; D013237:Stereoisomerism; D009435:Synaptic Transmission / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011955:Receptors, Drug; D012702:Serotonin Antagonists; D012701:Serotonin; D011433:Propranolol; D004298:Dopamine